Stoke Therapeutics (STOK) Earnings Date & Reports

Stoke Therapeutics Inc is a biotechnology company dedicated to restoring protein expression by harnessing the bodys potential with RNA medicine... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

STOK is expected to report earnings to fall 2.75% to -76 cents per share on August 10

Stoke Therapeutics STOK Stock Earnings Reports

Q2'26

Est.

$-0.77

Q1'26

Beat

by $0.02

Q4'25

Missed

by $0.23

Q3'25

Missed

by $0.07

Q2'25

Beat

by $0.10

The last earnings report on May 07 showed earnings per share of -79 cents, beating the estimate of -81 cents. With 569.52K shares outstanding, the current market capitalization sits at 1.87B.

View a ticker or compare two or three

Compare

STOK

Setup

Daily Signal:

Description

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

Last 5 trading days

View AI-Driven Trading for STOK